- Eight values confirm or rule out PCOS: total testosterone, SHBG, DHEA-S with androstenedione, AMH, and the four that exclude look-alikes, TSH, prolactin, 17-hydroxyprogesterone, FSH and LH (1).
- Four more are due at diagnosis for every woman: a 75 g glucose tolerance test, fasting glucose, HbA1c and a lipid profile, then glucose again every one to three years (1).
- Fasting insulin and HOMA-IR are not on the list; the guideline says the available insulin assays are not recommended in routine care (1).
- Cycle day 2 to 5, early morning, fasting, covers everything in one draw. On the pill, androgens cannot be judged; the guideline asks for three months off first (1).
Why the blood test comes first
A PCOS diagnosis is partly a diagnosis of exclusion: the guideline requires that thyroid disease, high prolactin and non-classic congenital adrenal hyperplasia are ruled out before the label is given, because each of them can produce the same irregular cycles and the same androgen signs (1). Blood also decides the second feature when the clinical picture is unclear: the guideline says measuring androgens is of greatest value in women with few or no visible signs (1).
And once PCOS is confirmed, the guideline asks for a metabolic check at diagnosis, whatever your age or weight: glucose handling and blood fats (1). Those numbers are the ground that everything else stands on, including which supplements make sense and how a training plan should be built. Without them, every plan is a guess. The basics article explains the rule of two these tests feed into.
The androgens, and AMH
Total testosterone is the main androgen. The guideline wants it measured by tandem mass spectrometry, written LC-MS/MS on lab forms, and says that the direct immunoassays many labs still use have limited accuracy and poor sensitivity for diagnosing high androgens in PCOS (1, 2). SHBG, the protein that binds testosterone, is measured alongside it, because the two together give the free androgen index, the guideline's estimate of the testosterone that is actually active (1).
DHEA-S and androstenedione, the adrenal androgens, come second: the guideline says they could be measured when testosterone is normal but the picture still points to PCOS, noting they are less specific and that DHEA-S falls with age (1). AMH, anti-Müllerian hormone, is the newest entry. In adults it can stand in for the ultrasound count of follicles, but it should never be the only test, it is not used within eight years of the first period, and it is lower on the pill (1, 3).
The four look-alikes
The guideline's diagnostic algorithm names four tests to exclude other causes: TSH for the thyroid, prolactin, 17-hydroxyprogesterone for non-classic congenital adrenal hyperplasia, and FSH, with LH, for the causes of missing periods that have nothing to do with androgens, such as very low body fat or intensive training (1). Where it is clinically indicated, a doctor will also think of Cushing's syndrome or an androgen-producing tumor; the guideline's warning sign for the latter is an androgen level well above the laboratory range, together with a fast onset (1).
Two notes on technique. Prolactin rises with stress and exercise, so the sample should be taken rested, without a dramatic needle experience, as the Endocrine Society's prolactin guideline puts it (4). And 17-hydroxyprogesterone must be taken early in the morning in the first half of the cycle, because it rises after ovulation and would otherwise look falsely high (5).
The metabolic four
The guideline recommends the 75 g oral glucose tolerance test as the most accurate test of glucose handling in PCOS, regardless of BMI, and says it should be considered for every woman planning a pregnancy (1). You drink a measured glucose solution after an overnight fast, and blood is taken before and two hours after (6). If the test cannot be done, fasting glucose and HbA1c, the three-month average, are the fallbacks, with what the guideline calls significantly reduced accuracy (1).
The lipid profile, total, LDL and HDL cholesterol and triglycerides, is due at diagnosis for every woman regardless of age and BMI, and afterwards as often as the overall cardiovascular risk suggests (1). Blood pressure belongs to the same visit, once a year (1). Glucose is rechecked every one to three years depending on your other risk factors (1).
Fasting insulin, and why it is not on the list
This surprises many women, because fasting insulin and HOMA-IR, a ratio calculated from fasting insulin and glucose, are everywhere online. The guideline's position is explicit: insulin resistance is a pathophysiological factor in PCOS, "however, clinically available insulin assays are of limited clinical relevance and are not recommended in routine care" (1). The methods that measure insulin resistance reliably are research tools, and the simple blood value varies too much between labs and days to steer decisions.
So the guideline measures the consequences instead, with the glucose tolerance test, and treats insulin resistance as present in principle, which is why lifestyle support is recommended for every woman with PCOS (1). If a doctor orders fasting insulin anyway, it is not wrong, but a normal result does not rule out insulin resistance and a high one does not need a supplement. The insulin resistance article goes deeper.
Which day of the cycle, and what the pill does
If you have a cycle, book the draw for day 2 to 5 of a bleed, early in the morning, fasting since the evening before. That single visit covers the androgens, 17-hydroxyprogesterone, FSH and LH, glucose and the lipids (1, 5). If your periods are irregular or absent, go on any day and tell the doctor the date of your last bleed; a progesterone test can show whether you ovulated (1).
On the combined pill, androgen results cannot be judged, because the pill raises SHBG and lowers androgen production. The guideline says that if the androgen test is essential, the pill should be withdrawn for a minimum of three months, with contraception managed otherwise in that time (1). AMH is affected too: in a study of 887 women, levels were 19 percent lower in pill users (3). Whether to pause the pill is a decision for you and your doctor, never a decision to make alone because an article said so.
How to ask, and what to take home
One sentence does most of the work: "I would like to rule PCOS in or out following the 2023 international guideline. Could we test these values, and could I have a printed copy of the results with the reference ranges?" Bring the dates of your last three bleeds, your medication and supplements including the pill, any earlier results, and the printed checklist.
In Germany, a gynecologist usually orders the cycle hormones and a general practitioner or endocrinologist the glucose and lipid set; many practices do both, and statutory insurance covers tests with a medical indication, so ask before you pay for anything privately. Take home three things: the printout, the lab method used for testosterone, and the date of the next glucose check. If a test is declined, ask for the reason and write it down. A second opinion is normal.
Reading the results without over-reading them
Reference ranges differ between laboratories and methods, which is why the guideline tells labs to use their own validated cut-offs for androgens and for AMH (1). A testosterone value from an immunoassay and one from LC-MS/MS are not comparable. A single raised value is not a diagnosis, and a single normal value does not exclude one; the pattern across values, your cycle history and the clinical examination together do, and that reading belongs to your doctor.
What the numbers can do for you is make the next steps concrete: a glucose result decides how urgent the metabolic side is, the androgen picture decides whether a cosmetic concern has a hormonal explanation, and the look-alike tests close doors that would otherwise stay half open. HERA's Blood Test Guide, the first of the four documents in the plan, organizes this list for your appointment and, where results exist, writes the rest of the plan around them.
Only a doctor can diagnose PCOS. This article is information from certified coaches, not medical advice, and it does not replace a consultation. Your doctor interprets your results.
References
- Teede HJ, Tay CT, Laven JJE, et al. Recommendations from the 2023 International Evidence-based Guideline for the Assessment and Management of Polycystic Ovary Syndrome. J Clin Endocrinol Metab. 2023;108(10):2447-2469. doi.org/10.1210/clinem/dgad463
- Rosner W, Auchus RJ, Azziz R, Sluss PM, Raff H. Utility, limitations, and pitfalls in measuring testosterone: an Endocrine Society position statement. J Clin Endocrinol Metab. 2007;92(2):405-413. doi.org/10.1210/jc.2006-1864
- Birch Petersen K, Hvidman HW, Forman JL, et al. Ovarian reserve assessment in users of oral contraception seeking fertility advice on their reproductive lifespan. Hum Reprod. 2015;30(10):2364-2375. doi.org/10.1093/humrep/dev197
- Melmed S, Casanueva FF, Hoffman AR, et al. Diagnosis and treatment of hyperprolactinemia: an Endocrine Society clinical practice guideline. J Clin Endocrinol Metab. 2011;96(2):273-288. doi.org/10.1210/jc.2010-1692
- Speiser PW, Arlt W, Auchus RJ, et al. Congenital adrenal hyperplasia due to steroid 21-hydroxylase deficiency: an Endocrine Society clinical practice guideline. J Clin Endocrinol Metab. 2018;103(11):4043-4088. doi.org/10.1210/jc.2018-01865
- American Diabetes Association Professional Practice Committee. Diagnosis and classification of diabetes: Standards of Care in Diabetes 2024. Diabetes Care. 2024;47(Suppl 1):S20-S42. doi.org/10.2337/dc24-S002